Considerable evidence is provided that in the obese mouse placenta, digoxin concentration elevation in the fetus is strongly correlated with the obesity-induced P-gp expression reductions during pregnancy [18], which shows that the potential protective function of P-gp is weakened in obesity. The gene discussed is PGP; the disease is obesity disorder.